FIELD: medicine.
SUBSTANCE: invention refers to pharmaceutics and concerns an agent to treat and prevent the cerebrovascular diseases, containing lithium salt wherein lithium cation is bound with organic acid chosen from the group: adipate, aspartate, benzoate, hammalinolenate, glycinate, gluconate, nicotinate, orotate, salicylate, citrate, and the method for treating said diseases.
EFFECT: invention provides clinical effectiveness in small doses of said agent.
10 cl, 1 tbl, 9 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT FOR PREVENTING AND TREATING NEURODEGENERATIVE PATHOLOGY AND VASCULAR DEMENTIA (VERSIONS) | 2014 |
|
RU2582962C1 |
| METHOD FOR PREVENTING AND TREATING NEURODEGENERATIVE PATHOLOGY AND VASCULAR DEMENTIA | 2014 |
|
RU2587617C1 |
| NEUROPROTECTIVE AGENT | 2016 |
|
RU2614697C1 |
| METHOD FOR OBTAINING ZINC SELENITE COMPOUND AS MEDICATION WITH NEUROPROTECTIVE EFFECT | 2006 |
|
RU2333762C2 |
| METHOD FOR PREPARING LITHIUM SALT OF COMENIC ACID AND USING IT AS ANTIOXIDANT, STRESS- AND NEUROPROTECTIVE AGENT | 2011 |
|
RU2477722C1 |
| 4-[(4-ACETOXYBENZOYL)AMINO]BUTYRATE OF LITHIUM, HAVING CEREBROPROTECTIVE ACTION | 2015 |
|
RU2617233C2 |
| MILK PRODUCT | 2012 |
|
RU2495580C1 |
| MEANS WITH ANTISTRESS, ANXIOLYTIC AND ANTIDEPRESSANT ACTIVITY AND COMPOSITION BASED THEREON | 2015 |
|
RU2617512C1 |
| METHOD OF TREATING NEUROLOGICAL DISORDERS | 2008 |
|
RU2492137C2 |
| PHARMACEUTICAL COMBINATION OF ATORVASTATIN AND NICERGOLIN FOR PREVENTING OR TREATING CEREBROVASCULAR DISEASE | 2011 |
|
RU2481124C1 |
